A detailed history of Conquis Financial LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Conquis Financial LLC holds 193 shares of AZN stock, worth $14,364. This represents 0.01% of its overall portfolio holdings.

Number of Shares
193
Holding current value
$14,364
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$63.2 - $79.58 $12,197 - $15,358
193 New
193 $12.6 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $231B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Conquis Financial LLC Portfolio

Follow Conquis Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conquis Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conquis Financial LLC with notifications on news.